Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K
Protein-protein Interfaces02:04

Protein-protein Interfaces

14.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Data-Driven Structure-Property Analysis and Rational-Efficient Retrosynthetic Design of 1,2-Dihydronaphtho[2,1‑<i>b</i>]furan Derivatives via Interpretable Machine Learning.

ACS omega·2026
Same author

Optimized Aqueous Sedimentation for Methoxyflavone Enrichment from <i>Kaempferia parviflora</i> and Its Mechanistic Suppression of Benign Prostatic Hyperplasia via TGF-β/SMAD/ERK Signaling.

ACS omega·2026
Same author

Genistein from Thai Fermented Soybean (Thua-nao) Attenuates Osteoarthritis Pathogenesis via Dual Inhibition of NF-κB and MAPK Signaling: Evidence from Ex Vivo, Computational, and In Vitro Models.

Journal of agricultural and food chemistry·2026
Same author

LB-PaCS-MD Guided Simulations Reveal Transient Stabilization during TCR-pMHC Dissociation.

Journal of chemical information and modeling·2026
Same author

Factors Influencing Non-urgent Emergency Department Visits: A Review of the Causes and Impact.

Cureus·2026
Same author

Machine Learning-Driven QSAR Modeling for pK<sub>a</sub> Prediction of Ionizable Lipids in Lipid Nanoparticles for Hepatic Gene Silencing.

International journal of molecular sciences·2026

Related Experiment Video

Updated: Jan 7, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.1K

Designing Potent HIV‑1 Protease Inhibitors Using Machine Learning and QSAR Approaches.

Saba Ali1, Ismail Dwi Putra2, Hathaichanok Chuntakaruk3

  • 1Center of Excellence in Computational Chemistry (CECC), Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand.

ACS Omega
|January 1, 2026
PubMed
Summary

Researchers developed new Human Immunodeficiency Virus type-1 (HIV-1) protease inhibitors using machine learning and QSAR models. These novel compounds show promise in overcoming drug resistance, outperforming existing treatments against HIV-1 variants.

More Related Videos

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.5K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.3K

Related Experiment Videos

Last Updated: Jan 7, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.1K
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.5K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.3K

Area of Science:

  • Medicinal Chemistry
  • Computational Biology
  • Drug Discovery

Background:

  • Acquired Immune Deficiency Syndrome (AIDS), caused by Human Immunodeficiency Virus type-1 (HIV-1), presents a persistent global health challenge.
  • Drug resistance, especially to protease inhibitors like Darunavir, limits the effectiveness of current antiretroviral therapies against HIV-1 variants.

Purpose of the Study:

  • To design novel, potent HIV-1 protease inhibitors by integrating machine learning (ML) and quantitative structure-activity relationship (QSAR) modeling.
  • To identify key molecular descriptors and structural features contributing to inhibitory activity against HIV-1 protease.
  • To evaluate the binding potential of newly designed inhibitors against wild-type and resistant HIV-1 strains.

Main Methods:

  • Development and comparison of multiple QSAR models (GFA, MLR, RF, GBR, XGBoost) using various molecular descriptors.
  • Application of SHAP analysis to interpret model predictions and identify critical molecular features influencing pIC50.
  • Structure-based molecular docking simulations to assess binding affinity and interactions of predicted inhibitors with HIV-1 protease.

Main Results:

  • Gradient Boosting Regressor (GBR) models achieved high accuracy (R² = 0.911 and 0.994) in predicting inhibitory activity.
  • Key predictive features included electronic charge at C53, low dipole moments, and a short C53-O54 bond length.
  • Five potent inhibitors (B01-B05) were designed, with B03 and B05 showing strong predicted binding to wild-type and variant HIV-1 proteases via hydrophobic and hydrogen bonds.

Conclusions:

  • The integrated QSAR-ML and structure-based approach successfully identified promising novel HIV-1 protease inhibitor candidates.
  • The designed compounds demonstrate potential for overcoming existing drug resistance mechanisms in HIV-1 treatment.
  • This study provides a foundation for developing next-generation antiretroviral therapies against resistant HIV-1 strains.